Prevention of cancers of the breast, endometrium and ovary

被引：106

作者：

Pike, MC ^{[1
]}

Pearce, CL ^{[1
]}

Wu, AH ^{[1
]}

机构：

[1] USC, Norris Canc Ctr, Los Angeles, CA 90089 USA

来源：

ONCOGENE | 2004年 / 23卷 / 38期

关键词：

prevention; breast cancer; endometrial cancer; ovarian cancer;

D O I：

10.1038/sj.onc.1207899

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A central epidemiological feature of cancers of the breast, endometrium and ovary is the sharp slowing down in their rate of increase with age around the time of menopause. The incidence of these tumors by the age of 70 years would be between fourfold and eightfold increased if the rapid increase with age seen in young women continued into old age. These phenomena can be explained by the different effects of ovarian hormones on cell division rates in the relevant tissues. Models of these effects provide a plausible explanation of most of the known epidemiology of each of the cancers, including the increase in breast cancer risk from menopausal estrogen-progestin therapy. Some recent epidemiological findings in endometrial and ovarian cancer suggest new avenues for possible chemoprevention of these cancers.

引用

页码：6379 / 6391

页数：13

共 113 条

[1] IS THE RISK OF CANCER OF THE CORPUS-UTERI REDUCED BY A RECENT PREGNANCY - A PROSPECTIVE-STUDY OF 765,756 NORWEGIAN WOMEN [J].

ALBREKTSEN, G ;

HEUCH, I ;

TRETLI, S ;

KVALE, G .

INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (04) :485-490

[2] Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial [J].

Anderson, GL ;

Limacher, M ;

Assaf, AR ;

Bassford, T ;

Beresford, SAA ;

Black, H ;

Bonds, D ;

Brunner, R ;

Brzyski, R ;

Caan, B ;

Chlebowski, R ;

Curb, D ;

Gass, M ;

Hays, J ;

Heiss, G ;

Hendrix, S ;

Howard, BV ;

Hsia, J ;

Hubbell, A ;

Jackson, R ;

Johnson, KC ;

Judd, H ;

Kotchen, JM ;

Kuller, L ;

LaCroix, AZ ;

Lane, D ;

Langer, RD ;

Lasser, N ;

Lewis, CE ;

Manson, J ;

Margolis, K ;

Ockene, J ;

O'Sullivan, MJ ;

Phillips, L ;

Prentice, RL ;

Ritenbaugh, C ;

Robbins, J ;

Rossouw, JE ;

Sarto, G ;

Stefanick, ML ;

Van Horn, L ;

Wactawski-Wende, J ;

Wallace, R ;

Wassertheil-Smoller, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1701-1712

[3] CELL TURNOVER IN THE RESTING HUMAN-BREAST - INFLUENCE OF PARITY, CONTRACEPTIVE PILL, AGE AND LATERALITY [J].

ANDERSON, TJ ;

FERGUSON, DJP ;

RAAB, GM .

BRITISH JOURNAL OF CANCER, 1982, 46 (03) :376-382

[4]

[Anonymous], 1973, HDB PHYSL SECTION 7

[5]

Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0

[6] SERUM HORMONE LEVELS IN PREMENOPAUSAL CHINESE WOMEN IN SHANGHAI AND WHITE WOMEN IN LOS-ANGELES - RESULTS FROM 2 BREAST-CANCER CASE-CONTROL STUDIES [J].

BERNSTEIN, L ;

YUAN, JM ;

ROSS, RK ;

PIKE, MC ;

HANISCH, R ;

LOBO, R ;

STANCZYK, F ;

GAO, YT ;

HENDERSON, BE .

CANCER CAUSES & CONTROL, 1990, 1 (01) :51-58

[7]

BERNSTEIN L, 1995, CANCER EPIDEM BIOMAR, V4, P437

[8] Intratumoral levels of estrogens in breast cancer [J].

Blankenstein, MA ;

van de Ven, J ;

Maitimu-Smeele, I ;

Donker, GH ;

de Jong, PC ;

Daroszewski, J ;

Szymczak, J ;

Milewicz, A ;

Thijssen, JHH .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1999, 69 (1-6) :293-297

[9] Heritability of mammographic density, a risk factor for breast cancer [J].

Boyd, NF ;

Dite, GS ;

Stone, J ;

Gunasekara, A ;

English, DR ;

McCredie, MRE ;

Giles, GG ;

Tritchler, D ;

Chiarelli, A ;

Yaffe, MJ ;

Hopper, JL .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (12) :886-894

[10] QUANTITATIVE CLASSIFICATION OF MAMMOGRAPHIC DENSITIES AND BREAST-CANCER RISK - RESULTS FROM THE CANADIAN NATIONAL BREAST SCREENING STUDY [J].

BOYD, NF ;

BYNG, JW ;

JONG, RA ;

FISHELL, EK ;

LITTLE, LE ;

MILLER, AB ;

LOCKWOOD, GA ;

TRITCHLER, DL ;

YAFFE, MJ .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (09) :670-675

← 1 2 3 4 5 6 7 8 9 10 →